Out-licensing

Compositions and methods for improving the growth characteristics of cells engineered to produce biologically active products such as antibodies or glycosylated proteins. More

A vaccine production strain of Bordetella bronchiseptica that produces Bordetella pertussis toxin in high yield More

Hybridoma cell lines capable of expressing monoclonal antibodies against FHA More

Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More

Novel methods of cell culture for production of human parvovirus B19 (B19). These specific cell lines demonstrate limited infectability and commonly produce little or no virus following initial inoculation with B19. More

These cell lines have been used to advance understanding of the molecular mechanisms of lymphomagenesis, and may be useful for the identification of molecular targets for agents that can be developed for the treatment of lymphomas and other tumors. More

A large variety of cell lines, each expressing a particular HLA molecule and the plasmids encoding them, including soluble HLAs. This technology has broad application for development of vaccines and immunotherapeutics. More

Monoclonal antibodies against HIV-1 viral protein R (Vpr) and the respective hybridoma cell lines expressing the same. More